ML-2

Information for ML-2

Description

Human acute myelomonocytic leukemia cell line; established from the peripheral blood of a 26-year-old man with acute myeloid leukemia (AML M4) at diagnosis of AML (following T-non-Hodgkin lymphoma and T-ALL) in 1978; sister cell lines are ML-1 and ML-3.

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
2
Transcriptional Factors
2
Peaks
2,787
Non-redundant peaks
2,312

Description

Cell_name
ML-2
Category
Cancer cell line
Disease
NCIt; C9154; Adult acute myeloid leukemia
Sex_gender_of_cell
Male
Age_of_donor
26Y

External IDs

Cellosaurus
CVCL_1418
Experimental Factor
EFO_0002238
BRENDA Tissue
BTO:0001885
Wiki
ML-2
ATCC
ML-2
Synonyms
ML2
All peaks ML-2
Download BED file
Non redundant ML-2
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for ML-2

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
ML-2 MEN1 GEO Homo sapiens GSE95511 Download (1,408)
ML-2 PSIP1 GEO Homo sapiens GSE95511 Download (1,379)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.